相关实验视频

Updated: Feb 17, 2026

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

怀孕前的母亲和新生儿结局,有和没有蛋白尿

Chaiti Saha¹, Shikha Chadha¹, Neha Agrawal¹

¹Obstetrics and Gynaecology, Dr. Baba Saheb Ambedkar Medical College and Hospital, Delhi, IND.

|February 16, 2026

概括

孕前与蛋白尿症表明母亲的并发症较高,新生儿的结果较差. 然而,非蛋白尿性孕前也存在重大风险,强调全面的患者评估以获得最佳管理.

科学领域:

产科和妇科产科和妇科
孕产妇和胎儿医学孕产妇和胎儿医学
怀孕中的病学在怀孕期间

背景情况:

孕前是导致孕产妇和新生儿发病率和死亡率的主要原因之一.
蛋白尿是常见的,虽然不是必不可少的,临床发现在孕前,与其预后价值辩论.
目前的指导方针承认蛋白尿与不良结果的关联,但其确切的作用需要进一步澄清.

研究的目的:

调查蛋白尿的存在与产前的孕产妇/新生儿结局之间的相关性.
为了比较母亲和新生儿并发症在妇女与怀孕前和没有蛋白尿.
评估蛋白尿在产前管理中的预后意义.

主要方法:

一项前性观察性研究,涉及600名患有妊娠前的妇女 (妊娠≥24周).
参与者被分为两组:A组 (孕前与蛋白尿,尿液测量棒≥2+) 和B组 (孕前没有蛋白尿).
评估了孕产妇和新生儿的结果,包括末端器官参与和子宫胎盘缺陷,通过使用t测试和千平方/费舍尔精确测试进行统计分析.

主要成果:

组A (蛋白尿) 呈现出明显更高的总体孕产妇并发症 (96.3%对70.3%),包括阴,胎盘突发和HELLP综合征.
甲组的整体新生儿并发症 (44.6%与23.9%) 也显著增加,死胎和子宫内生长限制 (IUGR) 的比率增加.
B组 (没有蛋白尿) 的子宫内死亡率 (IUD) 和新生儿重症监护室 (NICU) 的入院率更高,这表明即使没有蛋白尿,也存在重大风险.

结论:

蛋白尿是与新生儿并发症增加和产前的母亲结果较差相关的重要标志物.
然而,蛋白尿不是唯一的决定因素;其他因素,如系统性器官参与和并发症,对于预测结果至关重要.
非蛋白尿性孕前仍然可能涉及严重的生化乱和管理挑战,需要进行蛋白尿评估之外的彻底临床评估.

关键词:

内部器官功能障碍内部器官功能障碍母亲和胎儿的结果.孕前催产素前症候群是什么孕前症并发症孕前症并发症蛋白质尿症是一种蛋白质尿症.严重的妊娠前症.

更多相关视频

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo

Published on: August 2, 2017

相关概念视频

Nephrotic Syndrome II : Assessment and Medical Management

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...

Overview of Protein Metabolism

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...

Nephrotic Syndrome III : Nursing Management

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...

Pathophysiology of Diabetes

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...